Fermanagh Weight Loss Clinic
If you have been researching medical weight loss options, you have probably come across both Ozempic and Mounjaro, and it is easy to assume they are simply two names for the same thing. They are not, and understanding the difference matters when it comes to choosing the right treatment for you. At Fermanagh Clinics, we help patients across Northern Ireland make sense of these options every week. Book an appointment or contact us if you would like to discuss your own circumstances.
Ozempic contains semaglutide and is licensed in the UK for managing type 2 diabetes. Mounjaro contains tirzepatide, a different active ingredient, and is licensed for both type 2 diabetes and weight management. This is why Mounjaro is the treatment we offer privately for weight loss at Fermanagh Clinics, while Ozempic remains a diabetes medicine prescribed through other routes.
What Is Ozempic?
Ozempic is a brand name for semaglutide, a medicine originally developed and licensed to help people with type 2 diabetes manage their blood sugar levels. It is not licensed in the UK as a weight loss treatment, even though weight loss can occur as a side effect of taking it for diabetes.
What Is Mounjaro?
Mounjaro contains tirzepatide, a different active ingredient that acts on two hormone pathways, GIP and GLP-1, rather than one. It is licensed in the UK both for type 2 diabetes and, at certain doses, for chronic weight management. This dual licensing is why Mounjaro is available as a dedicated, clinically appropriate option for private weight loss support.
Reasons people often confuse the two include:
- Both belong to a similar family of injectable medicines given once weekly
- Both were originally developed with diabetes management in mind
- Media coverage has often used the names interchangeably
- Both are administered using a similar pre-filled pen device
Ozempic vs Mounjaro: Side By Side
| Feature | Ozempic | Mounjaro |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| UK licensed use | Type 2 diabetes management | Type 2 diabetes and weight management |
| Mechanism | GLP-1 receptor agonist | Dual GIP and GLP-1 receptor agonist |
| Dosing frequency | Once weekly | Once weekly |
| Available at Fermanagh Clinics | No | Yes |
How Does The Dosage Compare?
Both Ozempic and Mounjaro are started at a low dose and increased gradually, which helps the body adjust and reduces the likelihood of side effects. Doses are never chosen by the patient and are always set and reviewed by a prescriber.
| Stage | Ozempic (Semaglutide) | Mounjaro (Tirzepatide) |
|---|---|---|
| Starting dose | 0.25mg once weekly | 2.5mg once weekly |
| Titration | Increased gradually every 4 weeks as advised | Increased gradually, typically every 4 weeks as advised |
| Maximum licensed dose | 2mg once weekly | 15mg once weekly |
| Administration | Subcutaneous injection via pre-filled pen | Subcutaneous injection via pre-filled pen |
A few points worth keeping in mind about dosing:
- The starting dose is not intended to produce significant weight loss, it allows the body to adjust
- Not every patient needs to reach the maximum dose to see meaningful results
- Dose increases are only made under clinical guidance, based on how you are responding and tolerating treatment
- Missing doses or self-adjusting can affect both results and safety, so any changes should always be discussed with your prescriber first
During your consultation and follow-up appointments, our team will review your progress and any side effects before deciding whether a dose change is appropriate for you.
What Mounjaro Offers For Weight Loss
Mounjaro has shown encouraging results in clinical trials for weight management, and its dual mechanism is one reason it has attracted so much interest. Some of the genuine benefits reported include:
- A reduction in appetite that can make portion control noticeably easier
- Slower gastric emptying, which supports a longer feeling of fullness
- Improvements in blood sugar regulation alongside weight loss, particularly relevant for patients with or at risk of type 2 diabetes, not a universal benefit for all weight-loss patients
- Clinically supported results when combined with dietary and lifestyle changes
As with any medicine, results vary between individuals, and Mounjaro is not a guaranteed or standalone solution. It works best as part of a wider, personalised plan.
Access And Eligibility
Mounjaro is a prescription-only medicine, and eligibility is assessed on an individual basis. Generally, suitability is considered where:
- Your BMI is 30 or above, or 27 or above with a weight-related health condition
- You have no medical history that would make treatment unsuitable
- You are prepared to attend regular follow-up appointments for monitoring
- You understand the treatment works alongside, not instead of, lifestyle changes
A full clinical assessment is required before any prescription is issued, which is something our team carries out during your first consultation.
How We Support Your Journey In Northern Ireland
We know that starting a new treatment can feel like a big step, so our approach is built around proper, personalised support rather than a one-size-fits-all prescription. This includes:
- A thorough initial consultation to review your health history and goals
- A personalised treatment plan, adjusted as your progress is reviewed
- Ongoing monitoring throughout your treatment
- Practical guidance on nutrition and activity to support your results
- A team you can contact directly with questions between appointments
How Do Side Effects Differ?
Because Ozempic and Mounjaro belong to a similar family of medicines, their side effect profiles overlap considerably, but there are some differences worth understanding before starting either treatment.
Side effects that both medicines commonly share include:
- Nausea, particularly in the first few weeks or after a dose increase
- Vomiting and diarrhoea
- Constipation
- Reduced appetite
- Injection site reactions, such as mild redness or irritation
The table below summarises how the two compare:
| Side Effect | Ozempic (Semaglutide) | Mounjaro (Tirzepatide) |
|---|---|---|
| Nausea | Common, usually mild to moderate | Common, usually mild to moderate |
| Gastrointestinal effects | Diarrhoea, vomiting, constipation reported | Similar pattern, sometimes more pronounced during dose increases |
| Appetite changes | Reduced appetite common | Reduced appetite common, often more noticeable |
| Injection site reactions | Occasional, usually mild | Occasional, usually mild |
| Onset pattern | Most noticeable after each dose increase | Most noticeable after each dose increase |
Because tirzepatide acts on two hormone pathways rather than one, some patients notice gastrointestinal side effects a little more strongly during the early weeks or when a dose is increased. This does not mean Mounjaro is less tolerable overall, but it does highlight why a gradual, closely monitored dose increase matters. Most side effects with either medicine tend to ease as the body adjusts, and our team will guide you through what to expect and how to manage symptoms at each stage.
If I Can Have Mounjaro, Can I Also Have Ozempic? Contraindications Explored
This is a question we are asked fairly often, and the honest answer is that eligibility for one treatment does not automatically mean eligibility for the other. Even setting aside the licensing differences covered earlier in this article, the two medicines share several of the same contraindications, since they belong to a similar drug class.
Both Ozempic and Mounjaro are generally considered unsuitable for patients with:
- A personal or family history of medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- A history of pancreatitis
- Severe gastrointestinal disease, such as significant delayed gastric emptying
- Known hypersensitivity to the active ingredient or any part of the formulation
- Pregnancy or breastfeeding, or plans to become pregnant in the near future
Additional factors that may affect suitability for either treatment include:
- A history of diabetic retinopathy, which requires closer monitoring on GLP-1 based medicines
- Significant kidney or liver impairment
- Other medications you are currently taking, particularly insulin or sulphonylureas
- A history of eating disorders, which requires careful clinical discussion
It is worth remembering that shared contraindications are only part of the picture. Even where someone has no contraindications at all, Ozempic is not licensed for weight loss in the UK, so it would not be offered for that purpose regardless of eligibility. This is why a full clinical assessment, rather than a checklist alone, is essential before starting either medicine. During your consultation, our team will review your full medical history to confirm which treatment, if any, is appropriate for you.
Frequently Asked Questions
No. Ozempic is licensed for type 2 diabetes management, not weight loss, so we do not prescribe it for that purpose. We offer Mounjaro, which is licensed for weight management, as our private weight loss injection.
This is not a direct comparison that can be made, because Ozempic has not been studied or licensed for weight loss. Mounjaro’s dual mechanism has shown strong results in its own weight management trials, but individual response always varies.
No referral is needed. You can book directly with us, and our team will carry out a full clinical assessment as part of your first appointment.
The most commonly reported side effects include nausea, vomiting, diarrhoea, and constipation, particularly during the early weeks as your body adjusts to treatment. Our team will talk you through what to expect at your consultation.
We are based at 24 Church Street, Irvinestown, Fermanagh, BT94 1EH, and we support patients from right across Northern Ireland.
Ready To Find Out More?
If you are in Northern Ireland and want clarity on which treatment is right for you, our team is here to help. We take the time to understand your health history and goals so that any plan we recommend genuinely fits you, not the other way around.
- Phone: 028 6862 1828
- Email: thepillboxpharmacy@gmail.com
- Address: 24 Church Street, Irvinestown, Fermanagh, BT94 1EH
Book your consultation today and take the first step towards a personalised weight loss plan.